Summary
In ten healthy, male subjects the acute effect of pentoxifylline (a methylxanthine derivative) on liver plasma flow was investigated by the extrarenal sorbitol clearance method and on cardiac output by impedance cardiography.
On the placebo day liver plasma flow decreased within 4 h from 769 to 683 ml·min−1 (P<0.05) and on the pentoxifylline day (300 mg i. v.) it increased from 764 to 801 ml·min−1 (NS). At the end of the experiment the difference between the groups was also significant (P<0.05).
There was no significant change in cardiac output, blood pressure or heart rate and individual changes in those values were not correlated with liver plasma flow. There was no correlation either between the plasma concentrations of pentoxifylline or its metabolites and the changes in liver plasma flow.
It is concluded that, relative to the spontaneous decrease in liver plasma flow at rest on the placebo day, pentoxifylline increased splanchnic perfusion independent of any change in cardiac output.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dettelbach HR, Aviado DM (1985) Clinical Pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 25: 8–26
Komarek J, Cartheuser C, Mansfeld C (1977) Der Effekt von Pentoxifyllin, Xantinol-nicotinat und Theophyllin auf das Kreislaufsystem, die myokardiale Dynamik und die linksventrikuläre Kontraktilität beim Hund im akuten Experiment. Arzneimittelforsch 27: 1932–1939
Ballet F, Chretien Y, Rey C, Poupon (1987) Pentoxifylline improves microcirculation in the cirrhotic liver — a study in the isolated perfused rat-liver. J Hepatol 5 [Suppl 1]: S8
Grangé JD, Jaillon P, Noblinski B (1987) La pentoxifylline: un traitement potentiel des cirrhoses avec hypertension portale. Gastroenterol Clin Biol 11: 161A
Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J (1988) Steady state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 95: 749–759
Koppenhagen K, Wenig HG (1979) Wirkung von Pentoxifyllin auf die Leberdurchblutung. Med Klin 74: 1254–1256
Vetterlein F, Halfter R, Schmidt G (1979) Regional blood flow determination in rats by the microsphere method during i. v. infusion of vasodilating agents. Arzneim-Forsch 29: 747–751
Porter JM, Baur GM (1982) Pharmacologic treatment of intermittent claudication. Surgery 92: 966–971
Hartmann A (1983) Effect of pentoxifylline on regional cerebral blood flow in patients with cerebral vascular disorders. Eur Neurol 22: 108–115
Rowell LB, Blackmon JR, Bruce RA (1964) Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43: 1677–1690
Swartz RD, Sidell FR, Cucinell SA (1974) Effects of physical stress on the disposition of drugs eliminated by the liver in man. J Pharmacol Exp Ther 188: 1–7
McLean AJ, McNamara PJ, duSouich P, Gibalci M, Lalka D (1978) Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther 24: 5–10
Daneshmend TK, Jackson L, Roberts CJC (1981) Physiological and pharmacological variability in estimated hepatic blood flow in man. Br J Clin Pharmacol 11: 491–496
Zito RA, Reid PR (1978) Lidocaine kinetics predicted by indocyanine green clearance. N Engl J Med 298: 1160–1163
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suren, A., Bauer, F.E., Rosenkranz, B. et al. Effect of pentoxifylline on liver plasma flow in normal man. Eur J Clin Pharmacol 41, 233–237 (1991). https://doi.org/10.1007/BF00315435
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315435